The person behind the work.
A founder working across medicines and the next frontier
Varun Sharma is a Glasgow-born British-Indian entrepreneur and the founder of NEUVIOR and the VARUNÉ portfolio. At NEUVIOR, he serves as CEO and CTO and is product architect of PHARMORIS. His work centres on a practical question: how can complex evidence become a useful decision, with a clear human owner responsible for what happens next?
The education of family business
His early education in business came from his father’s corner shop. Writing in Startups Magazine, he recalls asking at seven why a chocolate bar sold for more than its purchase cost, and learning how margins support the costs of running a business. He connects those lessons in cash, customer behaviour and trust to his present interest in systems that turn ambition into reliable execution.
Building medicines intelligence
NEUVIOR gives that approach a focused setting. PHARMORIS is being developed as a staff-facing, human-governed medicines-operations system: a way to connect reviewable evidence, authorised decisions and accountable follow-through. Varun leads the product’s architecture alongside the company’s direction. The work remains in controlled, non-production development; its ambition is to make the route from evidence to action more explicit, rather than leave responsibility scattered across disconnected records.
A public argument about implementation
His published work follows the same thread. In pharmaphorum, he examines why medicines approval does not automatically become access. In TechRadar Pro, he asks how organisations can tell whether they retain control of an AI system. His September 2026 Express Pharma contribution considers the proofs behind India’s pharmaceutical capability. As a guest on AI Ethics Now, the University of Warwick IATL podcast, he discusses when an AI suggestion becomes a decision for which a person or institution must answer.
The wider VARUNÉ portfolio
VARUNÉ Bio is the lead company within Varun’s VARUNÉ portfolio. Operated by VARUNÉ BIOSYSTEMS LTD, it defines ingredient and formulation research for cosmetics and medicinal applications, with skincare as the first application focus. Molecular formulation science connects programmes in skin pigmentation, polar-associated functional polymers and biochemical light. Under-eye tone is the first application within skin pigmentation. Current work is literature synthesis and programme definition; completed laboratory studies and validated ingredients are not claimed. VARUNÉ Space Systems and VARUNÉ Intelligence retain their separate exploratory directions.
From research questions to things worth building
VARUNÉ Labs is the separate planned physical science-park development, aligned with VARUNÉ Intelligence’s exploratory AI, robotics and engineering direction. VARUNÉ Intelligence Ltd (SC857816) operates the Labs website. VARUNÉ Bio’s asset-light research model uses specialist collaboration and established facilities as programmes develop; it does not occupy an operating Labs facility. VARUNÉ Group is the shared portfolio brand, not a legal parent company. Across these distinct businesses and programmes, Varun’s connecting interest is how ideas become useful through human judgement, disciplined development and practical implementation.
Historical identity note. A limited number of earlier publisher and public records use Varun Cruz. The name is retained here only to connect those records to Varun Sharma. Use Varun Sharma for current biographies, titles and metadata.